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The fundamental challenge of aging and long-term survivorship is maintenance of 
functional independence and compression of morbidity despite a life history of disease. 
Inasmuch as immunity is a determinant of individual health and fitness, unraveling novel 
mechanisms of immune homeostasis in late life is of paramount interest. Comparative 
studies of young and old persons have documented age-related atrophy of the thy-
mus, the contraction of diversity of the T cell receptor (TCR) repertoire, and the intrinsic 
inefficiency of classical TCR signaling in aged T cells. However, the elderly have highly 
heterogeneous health phenotypes. Studies of defined populations of persons aged 75 
and older have led to the recognition of successful aging, a distinct physiologic construct 
characterized by high physical and cognitive functioning without measurable disability. 
Significantly, successful agers have a unique T cell repertoire; namely, the dominance of 
highly oligoclonal αβT cells expressing a diverse array of receptors normally expressed 
by NK cells. Despite their properties of cell senescence, these unusual NK-like T cells 
are functionally active effectors that do not require engagement of their clonotypic TCR. 
Thus, NK-like T cells represent a beneficial remodeling of the immune repertoire with 
advancing age, consistent with the concept of immune plasticity. Significantly, certain 
subsets are predictors of physical/cognitive performance among older adults. Further 
understanding of the roles of these NK-like T cells to host defense, and how they inte-
grate with other physiologic domains of function are new frontiers for investigation in 
Aging Biology. Such pursuits will require a research paradigm shift from the usual young-
versus-old comparison to the analysis of defined elderly populations. These endeavors 
may also pave way to age-appropriate, group-targeted immune interventions for the 
growing elderly population.
Keywords: CD16, CD56, cell senescence, functional performance, immune remodeling, NKG2D, plasticity, 
TCR-independent
Abbreviations: 3MS, average of three tests of the modified minimental examination; ADL, activities of daily living; GMFI, 
geometric mean fluorescence intensity; IFN, interferon; IL, interleukin; TCR, T cell receptor; TNF, tumor necrosis factor.
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iNTRODUCTiON: ALTeRATiONS iN 
CLASSiCAL T CeLL-MeDiATeD 
iMMUNiTY DURiNG AGiNG
Studies comparing young and old humans and mice have led to 
a voluminous body of literature showing a general age-related 
decline in various physiologic functions. In the immune system, 
among the most notable age-dependent physiologic retrogres-
sions in the T cell compartment are inefficiencies in classical 
T cell receptor (TCR) signaling, thymic involution, contraction 
of the naïve T compartment, expansion of the memory T cell 
compartment, and overall shortening of telomeres (1–8). At the 
cellular level, aged CD4+ and CD8+ T cells have a deficiency in the 
expression of CD28 that coincides with highly shortened telom-
eres, high levels of expression of mitotic inhibitors, such as p16 
and p53, and a severe limitation or complete lack of mitotic activ-
ity (9–13). All of these alterations have been argued to underlie 
the relative poorer antigen-specific T cell-dependent immunity 
among older adults compared to younger persons.
HeTeROGeNeiTY OF PHeNOTYPeS OF 
OLDeR ADULTS
Older adults (generally defined as those aged ≥65 years), however, 
have highly heterogeneous health and immune phenotypes. They 
range from the frail and chronically ill residents of long-term care 
facilities to the community dwellers that are living independently 
(14–17). Many of them retain their ability to mount vaccine 
responses, including to the pandemic and seasonal influenza 
vaccines, and to the zoster vaccine (18–22). There are evidences 
of functionally active virus-specific T cells during new and reac-
tivated latent infections (23–25). Old age has also become less 
of hurdle in the setting of organ transplantation for either organ 
donors or recipients (26–29). Thus, aging is not synonymous with 
poor health, or that the elderly are not mere defective versions of 
the young.
Heterogeneity of older adults provides a compelling rationale 
for a re-appraisal of “immunosenescence.” In its current usage, 
the term refers to the poorer degree of immune responsiveness 
of older adults relative to that seen in the young, a generalized 
and vague definition that has not substantially differed from 
the original concept proposed by Walford in the 1950s (30). 
Learning from epidemiological and geriatric studies (14–17, 31), 
we have articulated the paramount importance for the analysis 
of defined populations of the elderly, instead of continuing with 
the usual young-versus-old comparative approach. Such research 
paradigm shift is a key toward unraveling immunopathways that 
underlie discrete physiologic constructs of aging, such as frailty 
and successful aging (32, 33).
iRReveRSiBLe LOSS OF CD28:  
A SiGNATURe OF AGiNG iN HUMAN  
T CeLLS
CD28 is the major co-stimulatory molecule that is required to 
sustain normal T cell activation (34) and for the elaboration of 
antigen-specific effector function in both naïve and memory 
compartments (35–37). In cohort studies, we provided the 
definitive proof for progressive loss of CD28 with chronologic 
aging (12). Such loss or absence of CD28 has long been thought to 
lead to deficiency or inefficiency of TCR signaling in aged T cells 
(10, 38). Indeed, mice with homozygous deletion of CD28 results 
in an immunosuppressed phenotype, since mouse CD28−/− T cells 
are anergic and prone to activation-induced cell death (35, 39).
The loss of CD28 on human T cells with aging (10, 12, 40) may 
not be surprising since CD28 expression is subject to transient 
downregulation during a normal immune response (41). In fact, 
deficiency of its expression is characteristic of continuous pas-
sages of T cell cultures (40, 42). These unusual CD28null CD8+ 
T cells have shortened telomeres (13), consistent with telomere-
dependent senescence (sometimes referred to as “replicative 
senescence”) akin to those reported for other human somatic 
cells (43–47).
Due to more rapid turnover, CD8+ T cells have higher rate 
of CD28 loss than CD4+ T cells (48, 49). CD28null CD4+ and 
CD8+ T cells are highly oligoclonal and have highly shortened 
telomeres, indicating their long replicative history (12, 13). They 
also have high expression levels of p16 and 53, and they have 
limited, if not complete lack of, proliferative capacity even under 
conditions of optimal stimulation via TCR/CD3 in the presence 
of interleukin (IL)-2 in vitro (11, 12, 50, 51). All these properties 
are consistent with replicative senescence.
CD28 loss and telomere shortening are properties of primates, 
being typical of elderly humans as described above, as well as 
for older macaques and other anthropoids (52–55). In contrast, 
mouse T cells maintain long telomeres, and neither CD4+ nor 
CD8+ T cells show perceptible telomere shortening with multiple 
cell divisions in vitro (56). Indeed, it takes at least four generations 
for the telomerase-deficient mouse to show quantitative shorten-
ing of telomeres (57), indicating mice clearly do not undergo 
telomere-dependent replicative senescence.
Clonal expansions of T cells are characteristic of old mice simi-
lar to old humans (58). However, mouse T cells do not lose CD28 
expression with chronologic aging. In fact, CD28 expression 
level may actually increase with age (59). Such species-specific 
difference in CD28 expression pattern between humans and 
mice is attributable to entirely non-homologous DNA sequences 
in the promoter regions of the CD28 gene (60) (Homo sapiens 
CD28, NCBI Gene 940, HGNC 1653; Mus musculus CD28, MGI 
88327, NCBI Gene 12487). These age-related loss/maintenance 
of telomeres and loss of CD28 underscore that transposition of 
data obtained from mouse studies to human biology is unsound. 
We have articulated that while aging mouse models are instruc-
tive about the general biology of aging, they do not substitute for 
analytical studies of human elderly subjects (61).
The loss of CD28 is generally irreversible, due to the direct 
inactivation of the gene promoter (42, 62). The transcriptional 
initiator, a DNA sequence module in the 5′ cis-acting CD28 regu-
latory region where the activator complex, including nucleolin 
and heterogeneous ribonucleoprotein-DOA, is unoccupied in 
senescent CD28null T cells (63). Nucleolin and heterogeneous 
ribonucleoprotein-DOA are found in senescent T cells, but they 
do not form a functional initiator complex. While mechanism(s) 
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underlying the failure of the assembly of this transcriptional 
complex remains to be investigated, it is clear that non-occupancy 
of the CD28 initiator results in a transcriptional block, leading to 
the absence of all splice forms of CD28 mRNA and the lack of 
expression of CD28 on the T cell surface (42, 64, 65).
CD28null T cells are resistant to apoptosis (66), which explains 
their persistence in circulation for years and their pervasive 
accumulation in  vivo with advancing age. This is attributed to 
constitutively high levels of expression of Bcl2 and Bcl-xL, with 
corresponding downregulation of Bax (12, 67). Bcl-independent 
pathways for the lifelong persistence of these cells have also been 
reported (68).
DE NOVO eXPReSSiON OF NK-ReLATeD 
ReCePTORS ON CD28null T CeLLS: 
FUNCTiONAL DiveRSiTY AND 
veRSATiLiTY OF AGeD T CeLLS
Whether they are naturally derived in vivo during aging, or in an 
in vitro senescence system, oligoclonal senescent CD28null T cells 
have a unique phenotype for their de novo acquisition of a diverse 
array of receptors normally expressed on NK cells (12, 50, 69, 70). 
The repertoire of NK-related receptors they express does not 
reflect the full complement of the many NK receptor genes 
normally expressed on NK cells (50). However, the NK-related 
receptors on aged CD28null T cells are expressed co-dominantly in 
varying combinations along clonal lineages. CD28null T cells with 
identical TCR CDR3 sequences, indicating their common origin 
from a single mother CD28+ T cell, may express different types of 
NK-related receptors (71, 72).
Whether the loss of CD28 is required for, or is an event inde-
pendent from, the expression of NK-related receptors remains to 
be examined. However, it is clear that differences in the patterns of 
expression of these receptors between NK cells and CD28null T cells 
are related to cell-specific differences in the regulatory modules 
of each NK-related receptor. For example, we have shown that 
differential expression of CD158b1 (KIR 2DL2) between T and 
NK cells are controlled by two distinct transcriptional regulatory 
motifs on the upstream cis-acting promoter region of the gene; 
namely, a proximal element at −51 and an AML site at position 
−98 for T and NK cells, respectively (73). Other investigators 
have reported the role of age-related epigenetic alterations. 
Differential induction of CD158d (KIR 2DL4) and CD158b2 
(KIR 2DL3) on T cells is related to methylation/demethylation on 
promoter regions of these two genes, in contrast to their classical 
promoter-driven expression as seen in NK cells (74–76). These 
studies suggest that there may be diverse regulatory machineries 
involved in the induction of NK-related receptors on T cells with 
aging. Given the diversity of these receptors and their apparent 
co-dominant expression, it will be of interest to examine whether 
and how expression of one NK-receptor affects the expression 
of another NK-receptor during the aging process. A particular 
interest is the regulation of expression of the prototypic recep-
tors CD56, CD16, and NKG2D on aged T cells. But regardless of 
whether such regulation occurs at the level of unique promoter 
motifs, or through structural alterations of chromatin that favor 
accessibility of the particular NK-receptor gene, or perhaps 
through posttranscription controls, it is clear that the acquisition 
of NK receptors by T cells corresponds with the elaboration of 
new effector function (77).
The phenomenal age-related expression of NK-related 
receptors on T cells has been associated with seropositivity 
to cytomegalovirus (CMV) (78). This is in line with reports 
about similar association of CMV serology with frequency 
of CD28null T cells, and such serological-cellular association 
has been argued to be a predictor of poor health outcomes of 
aging (79, 80). It has also been suggested that CMV infection 
may lead to the emergence of these senescent T cells that are 
considered dysfunctional or non-functional (81–83). However, 
such studies are purely associational rather than causal. Further, 
the association is not universal. The cited studies are mostly 
from those on elderly populations in Northern Europe where 
CMV exposure appears to occur gradually over the life span, 
which might explain the high CMV seropositivity in old age 
(80). In the United States, CMV exposure is already widespread 
at early adolescence (84). Yet, we have shown that senescent 
NK-like T cells are rarely found among young Americans 
(12, 32). Importantly, we found very high titers of anti-CMV 
antibody among older adults and found no clinical evidence of 
CMV disease. Indeed, another cohort study showed CMV sero-
positivity alone is an insufficient measure of health risk among 
older Americans (85). In addition, populations of CMV-specific 
T cells have been found to be functional with clear beneficial 
antiviral effects (68, 86, 87). A recent experimental study has 
shown further that CMV by itself does not induce replicative 
senescence for T cells (25). CMV disease is undoubtedly serious 
whether it happens at an early or old age. However, the causative 
role of CMV in human T cell senescence is yet to be proven. 
Broader experimental studies are needed to determine what 
particular environmental and/or endogenous factors trigger, 
drive, and maintain populations of senescent NK-like T cells 
in vivo during the aging process.
The array of NK-related receptors expressed on aged CD28null 
T cells is summarized in Figure 1. They include the prototypic 
stimulatory NK receptors, CD16, CD56, and NKG2D. They may 
also express CD161, and various inhibitory NK receptors such 
as CD94 and NKG2A, and members of the CD158 killer cell 
immunoglobulin-like receptor family (12, 50, 69, 72, 77, 88–90). 
Unlike the selective single allelic expression for TCR, NK-related 
receptors are expressed co-dominantly on aged T cells.
In addition to shortened telomeres, high p16/53 expression 
levels, and irreversible loss of CD28, aged NK-like T cells express 
two other markers of senescence, namely, KLRG1 and CD57 (81, 
91, 92). KLRG1 is an inhibitory NK-related receptor that has been 
shown to actively suppress classical TCR signaling (93). CD57 is 
an adhesion molecule that is typically expressed on terminally 
differentiated T cells. Although it is still unclear if CD57 itself is 
a signaling receptor that dictates or alters T cell effector function, 
its expression on T cells is biomarker for cell cycle arrest in aged 
T cells (91, 94). It might be noted that CD57 is also expressed on 
highly differentiated NK cells (95, 96). However, whether such 
CD57+ NK cells are senescent, and that CD57 directly controls 
NK cell function are also not yet known.
FiGURe 1 | Diagrammatic comparison between conventional CD28+ and senescent CD28null NK-like T cells. This illustration summarizes findings from 
various investigators as described in the text. The diagram shown was modified from (32) with permission from Aging and Disease journal under the terms of 
Creative Commons Attribution License (CC BY). This license allows the unrestricted use, distribution, modification, and reproduction in any medium by the author 
with credited citation of the original publication.
4
Michel et al. NK-Like T Cells in Aging
Frontiers in Immunology | www.frontiersin.org November 2016 | Volume 7 | Article 530
Despite their senescent properties, CD28null NK-like T cells 
are highly functional and versatile. While there is general trend 
for the varying inefficiencies of classical TCR signaling during 
aging (1, 2, 97–99), there could still be residual TCR signaling as 
exemplified by long-lived memory T cells in the context small pox 
and polio vaccination (100, 101). Indeed, experimental studies 
showing unusually high constitutive level of expression of inter-
feron (IFN) γ in CD28null T cells can further increase following 
ligation of TCR/CD3 (38, 94, 102). Such residual TCR-driven 
response may be attributed to other co-stimulatory molecules, 
such as 41BB ligand, OX40, CD70, and CD58, which substitutes 
for the defunct CD28 (103–107).
More significantly, we have reported that effector activities of 
CD28null NK-like CD4+ and CD8+ T cells are directly attributable 
to signaling of the NK-related receptors they express in a totally 
TCR-independent manner (12, 70). We have shown that CD56-
driven and NKG2D-driven expression of the early activation 
cell surface antigen CD69; the intracellular expression of IL-4, 
IFNγ, CD107b/LAMP2, perforin, and granzyme; and the late 
cell surface expression of exocytosis protein CD107a are to be 
as effective as, if not better than, classical TCR stimulation. In 
fact, the CD56-/NKG2D-driven TCR-independent expression of 
perforin, granzyme, and CD107a occur in both CD4+ and CD8+ 
NK-like T cells. This indicates that the conventional “helper” 
and “cytotoxic” designations for CD4+ and CD8+ T cells, respec-
tively, are not instructive about of the biology of T cells in old 
age. Similarly, the expression of CD154 (CD40 ligand) on aged 
T cells does not follow the usual CD4 helper paradigm. CD154 
is lost on senescent CD28null CD4+ NK-like T cells but is gained 
by senescent CD28null CD8+ NK-like T cells (38, 108, 109). This 
suggests that the latter cell subset is a potential target to boost 
humoral immunity in the elderly.
AGe-DePeNDeNT ACCUMULATiON  
OF CD28null NK-LiKe T CeLLS wiTH 
OLiGOCLONAL TCRs: iMMUNe 
RePeRTOiRe ReMODeLiNG CONSiSTeNT 
wiTH PHYSiOLOGiC PLASTiCiTY  
iN OLD AGe
Physiologic systems are optimized toward reproduction, after 
which the goal is individual survival (110). There is evolutionary 
conservation of biological pathways that ensure individual sur-
vival beyond reproductive maturity (111, 112), including a variety 
of genes referred to as “longevity assurance” genes that promote 
long-term survival (113–116). Older organisms are essential in 
maintaining population structures particularly among social 
animals and are therefore involved ultimately in the perpetuation 
of the species (112, 117–119).
Immunity is an evolutionary determinant of individual fitness 
and survival (120–122). The accumulation of NK-like CD28null 
T  cells with advancing age represents a remodeling of the 
immune repertoire as a compensatory mechanism for the general 
age-related losses in conventional T cell-dependent immunity 
(123). As described previously, there is thymic atrophy with age 
leading to impaired production of new naïve T cells, making 
older adults unable to respond to new and emerging pathogens 
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in an antigen-specific manner (3, 124). With antigenic exposure 
through life, there is progressive contraction of the naïve T cell 
compartment, with corresponding expansion of memory and 
senescent T cell compartment. These events over the lifespan 
result in the contraction of diversity of the clonotypic TCR 
repertoire (5, 49). With cycles of expansion and death of T cells 
during antigenic challenges, the phenomenal accumulation of 
apoptosis-resistant CD28null NK-like T cells is likely a protection 
against clinical lymphopenia, which is very rare among older 
adults (125, 126).
The acquisition of a diverse array of NK-related receptors on 
CD28null T cells maintains immunologic diversity in old age. As 
discussed previously, there is co-dominant expression of diverse 
NK-related receptors along clonal lineages of CD28null T cells in 
late life. This is in stark contrast to the conventional clonotypic 
TCR diversity that is characteristic of the young. Signaling of 
these NK-related receptors effectively imparts an innate function 
to aged T cells (12, 70); hence, we had originally introduced the 
term “NK-like T cells” to emphasize their NK-related receptor-
driven, TCR-independent effector function (50). The term under-
lines the diverse array of NK-related receptors expressed along 
oligoclonal TCRαβ lineages, in contrast to convention αβTCR 
repertoire diversity in the young (12). NK-like T cells are distinct 
from conventional NKT cells (or invariant iNKT cells), which 
are identified a single invariant TCR AV24BV11 that recognizes 
glycolipid antigens presented in the context of CD1d instead of 
conventional HLA antigen-presenting molecules (127, 128).
NK-like T cells compensate for the corresponding age-related 
functional loses in the NK cell compartment (32). NK cell num-
bers are largely maintained through life, but skewing of certain NK 
cell subsets with aging have been reported (129). We have shown 
that octo-/nona-genarians have contracted pools of CD56+ and 
CD16+ NK cells, which are accompanied by corresponding age-
dependent gains of CD56 and CD16 expression on both CD4+ 
and CD8+ T cells (32, 70). As already described previously, CD56 
ligation alone can drive T cell effector activities. The function of 
CD16 on NK-like T cells remains to be examined.
Induction of NK-related receptors on T cells may not be 
surprising since T cells and NK cells originate from a common 
lymphoid progenitor. We have shown that NK cells have an 
abundance of untranslated, but re-arranged, TCRαβ mRNA with 
sequences identical to those seen in T cells (130). Thus, induc-
ibility of NK-related receptors in senescent CD28null NK-like 
T cells is consistent with functional plasticity of T cells (131–133). 
Although the intricacies of T cell plasticity are still being inves-
tigated, such plasticity re-directs the elaboration of effector 
activities to ensure a vigorous immunity. In old age, signaling of 
effector activities of NK-like T cells through NK-related receptors 
is an adaptation of the aging immune system. Such adaptation is 
a way to maintain immune homeostasis despite the inefficiency 
of classical TCR signaling and the contraction of diversity of the 
repertoire of clonotypic TCRs. NK-like T cells are highly resistant 
to cell death (12) and may represent Darwin’s “fittest” lympho-
cytes that contribute to immune function into old age.
Cell senescence is undoubtedly a characteristic of old organ-
isms, and it contributes to age-related malfunction in various 
tissues/organs (44, 134, 135). However, cell senescence also has 
physiologic benefits. Among these is its role in tumor suppres-
sion (134, 136, 137). Cell senescence also plays a role in tissue 
repair (138), such as in the prevention of fibrosis in liver, skin, 
kidney, and heart, and in the prevention of atherosclerosis 
and pulmonary hypertension (139). In addition, there is also 
programed cell senescence, which is an essential component of 
embryogenesis (140–142). Along these lines, the age-dependent 
emergence of functionally competent senescent NK-like CD28null 
T cells represents a significant and beneficial remodeling of the 
immune repertoire (123).
T cell repertoire remodeling through the de novo expression of 
NK-related receptors along clonal lineages of senescent CD28null 
T cells is also consistent with age-related functional plasticity in 
certain organ systems. For example, there is age-related structural 
and functional decline in the central nervous system that leads to 
varying degrees of cognitive impairment, such as dementia and 
Alzheimer’s disease. There is heritability of high cognitive func-
tion into old age (143, 144). The roles of specific genes or gene 
polymorphisms, and epigenetic programs have been reported 
(114, 115, 119, 145–150). But the apparent “default” trajectory 
of age-related cognitive decline may be altered by physical 
activity, inclusive of regimented exercise, strength training, or 
usual activity such as walking. This has been best illustrated by 
improvement of various aspects of cognitive function, including 
memory and learning, among older adults engaged in regular 
physical activity (151–158). Functional brain imaging show 
extraordinary brain networks of neurocognitive performance 
following physical activity (159–161). In experimental animals, 
physical activity elicits an array of genes, along with epigenetic 
changes, associated with improvement in neurobehavioral 
performance (162–165). While the mechanisms underlying the 
improvement of brain/cognitive function with physical activity 
need to be examined further, aging of the brain is undoubtedly 
amenable to modulation.
Similarly, aging leads to a decline skeletal muscle function, 
including an age-related inefficiency of muscle mitochondria. Yet, 
the aging skeletal muscle is functionally plastic. Whereas certain 
gene polymorphisms have been implicated to maintain muscle 
function with age (166), physical activity has been shown to 
improve muscle and mitochondrial function among older adults 
(167–170). An important component of physical activity-induced 
improvement of function of the aging muscle is the equally plas-
tic satellite cells that maintain muscle organization (171, 172). 
Clearly, certain physiologic systems including immune cells are 
functionally plastic, a property that may be exploited to maintain, 
if not improve, functional performance in old age.
NK-LiKe T CeLL SUBSeTS ARe 
BiOiNDiCATORS OF SUCCeSSFUL  
AGiNG AND LONGeviTY
As described previously, older adults are highly heterogeneous, 
with varying health phenotypes and life expectancy. An improved 
understanding of this heterogeneity has been facilitated by 
objective measurements of physical and cognitive function. Such 
measurements have led to better stratification of elders; from 
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frail residents of long-term care facilities, to successfully aging 
community dwellers (16, 31, 153, 173–177). Thus, we have been 
proponents for the integration of immunity with other domains 
of function (32).
Integration of immunity to other physiologic systems may 
be best illustrated by our cross sectional study of the All Stars 
cohort (70) of the survivors from the Cardiovascular Health 
Study, a multicenter long-term study of aging (16, 178, 179). 
Categorization of elders was based on cognition scores (3MS), 
measured by the average of three tests using the modified 
minimental examination (180), and self report of difficulty in 
performing activities of daily living (ADL), namely, dressing, 
toileting, transferring, eating, and bathing (181). High func-
tioning (or “unimpaired”) was defined as 3MS score >80 and 
ADL =  0. The data showed that the stimulatory NK-related 
receptors CD16, CD56, and NKG2D in all T cell subsets were 
the most prominent cellular components of the immune 
signature of the high functioning group as determined by fac-
tor analysis. In contrast, the inhibitory NK-related receptors 
NKG2A, CD158a, and CD158e comprised the cell signature of 
the functionally impaired. In line with these fingerprints, logis-
tic regression analysis of the same dataset showed CD56 and 
CD16 expression was significant predictors of high functional 
performance. In contrast, NKG2A and CD158a were negative 
predictors. More importantly, CD28null T cells in the CD4 but 
not in the CD8, compartment expressing these four NK-related 
receptors were the cell subset predictor of high cognitive/physi-
cal functioning.
Another way to illustrate the relationship between NK-like 
CD28null T cells and physical/cognitive functioning is shown 
in Figure 2 with a three dimensional plot for CD16 or CD56 
expression levels (measured as GMFI, geometric mean fluores-
cence intensity), 3MS cognition score, and gait speed. The latter 
measure of physical function was determined by a 4-m walk 
test that has been standardized/validated from various cohort 
studies (16, 176). The data show a clear segregation between 
the high functioning and functionally impaired elders. This is 
surprising given that “impaired” and “unimpaired” categories in 
this graphical illustration are very loosely defined by ADL ≥ 1 
and ADL =  0, respectively. Therefore, it will be of significant 
interest to determine if this three-way relationship between 
subsets of NK-like T cells, physical function, and cognitive 
ability translates into vigorous immune defense. In addition, 
the underlying mechanistic link(s) between these three physi-
ologic systems will be instructive about integrative physiology 
of successful aging.
NK-LiKe T CeLLS iN YOUNG PeRSONS 
wiTH CHRONiC DiSeASeS: A CASe FOR 
ANTAGONiSTiC PLeiOTROPY
NK-like CD28null T cells represent a beneficial remodeling of the 
T cell repertoire with aging. Paradoxically, similar cells have also 
been found among young patients with chronic immune-medi-
ated diseases in an age-disproportionate manner. We have shown 
the infiltration of CD56+ CD28null CD4+ T cells in extra-articular 
lesions in rheumatoid arthritis (182). Inflammatory CD56+ 
T cells have been reported in coronary artery disease, asthma, 
ulcerative colitis, and chronic hepatitis C disease (183–186). 
NKG2D+ CD28null T cells have some tumor-promoting activ-
ity in experimental settings (187, 188) and as inflammatory 
mediators in Wegener’s granulomatosis, rheumatoid arthritis, 
juvenile-onset systemic lupus erythematosus, and celiac disease 
(189–192).
Many of these diseases have characteristic systemic upregula-
tion of TNFα (193). We have shown that TNFα can directly block 
the CD28 transcriptional initiator (65, 194). In a TNFα-rich 
environment, such as in the case of rheumatoid arthritis, we 
found that anti-TNF therapy prevents the TNFα-induced loss of 
CD28 on the residual CD28+ CD8+ and CD4+ T cells, but the 
numbers of CD28null T cells remain the same (194). Whether or 
not TNFα induces the gain NK-related receptors has not yet been 
examined.
Interestingly, CD56+/NKG2D+ T cells also have beneficial 
effects in disease settings. Regulatory CD56+ CD28null CD8+ 
T cells and NKG2D+ T cells have been reported in rheumatoid 
arthritis and in juvenile-onset systemic lupus erythematosus, 
respectively (195, 196). Similar NK-like T cell subsets appear to 
be normal components of regional host defense in the gut. They 
may have auxiliary antitumor effect and have been associated 
with antiviral immunity in the setting of allergies and chronic 
hepatitis B disease (197–200).
Such age-disproportionate emergence of senescent CD28null 
NK-like T cells supports the provocative idea that premature 
senescence of T cells is a critical factor in the pathogenesis and 
clinical prognosis of chronic diseases of the young (201). These 
apparent beneficial and detrimental effects of certain NK-like 
T  cell subsets among young patients, and the beneficial effects 
of similar cells during aging as described above, are consistent 
with the evolutionary concept of antagonistic pleiotropy (202). 
This concept posits that genes and biological pathways that are 
beneficial in the young may be detrimental in the old, and vice-
versa. Therefore, a scientific challenge is to determine conditions 
in disease states of the young where CD28null NK-like T cells 
might exert a pathogenic effect. It will be of similar interest to 
determine what drives the accumulation of beneficial senescent 
CD28null NK-like T cells during the aging process.
CONCLUSiON: THe CHALLeNGe OF 
HARNeSSiNG BeNeFiTS OF CD28null  
NK-LiKe T CeLLS
The expression of NK-related receptors along clonal lineages 
of CD28null T cells with aging clearly represents a reshaping or 
remodeling of the immune repertoire. T cell signaling through 
these receptors independent of the TCR also illustrates the 
emerging theme that cell senescence may not necessarily be 
synonymous with dysfunction. One scientific challenge is to 
determine what drives the induction of diversity of expression 
of NK-related receptors on T cells with advancing age. Another 
is to determine whether the TCR-independent effector func-
tion of NK-like T cells translates into vigorous immune defense 
FiGURe 2 | NK-like T cells are linked to high cognitive and physical function. Data shown are 3D scatter plot summaries from the re-analyses of our data 
from the All Stars cohort of the Cardiovascular Health Study (70). CD16 and CD56 expression on CD4+ CD28null and CD8+ CD28null T cells are expressed as GMFI, 
which was determined by multicolor flow cytometry. Older adults were grouped as unimpaired (solid triangles) or impaired (open circles) based on a simple criterion 
of ADL = 0 and ADL > 1, respectively. Measurements of 3MS cognition score and gait speed and ADL scoring are as described in the text.
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and/or immune surveillance in late life. A  corollary interest 
is a possible dual functionality of these T cells, namely, their 
ability to trigger a classic TCR-driven response, while triggering 
a complementary innate TCR-independent response mediated 
through the particular NK-receptor(s) they express. Plausibility 
of this dual function has been shown experimentally for the 
interaction between tumor cells and particular NK-like CD8+ 
T cell lines in  vitro (203). An equal challenge is to elucidate 
the paradoxical age-disproportionate accumulation of NK-like 
T cells in disease states. Whether they represent cells involved 
in tissue repair or if they are true pathogenic effectors will be 
instructive into harnessing or dampening their effector func-
tion in disease settings. During the aging process, the most 
significant challenge is to determine how and why particular 
subsets of NK-like CD28null T cells are closely linked to physical 
performance and cognitive ability. Dissecting these mecha-
nisms will depend on the analyses of defined populations of the 
elderly, rather than continuing with the usual young-versus-old 
comparisons.
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